These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5003902)

  • 1. Glybenclamid (HB 419) and the prediabetes of subtotally pancreatectomized rats.
    Goberna R; Fussgänger RD; Raptis S; Ditschuneit H; Pfeiffer EF
    Horm Metab Res; 1969 Jul; 1(4):175-7. PubMed ID: 5003902
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
    Loubatières A; Ribes G; Mariani MM; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
    [No Abstract]   [Full Text] [Related]  

  • 3. Different amounts of insulin secretion following an equal total decrease of blood glucose as an indication of possible extrapancreatic activities of different sulfonylurea drugs.
    Beyer J; Haupt E; Cordes U; Kutschera J; Schöffling K
    Horm Metab Res; 1973 Jan; 5(1):9-13. PubMed ID: 4196346
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of insulin and glybenclamid on the intestinal disaccharidases of subtotally pancreatectomized rats.
    Rommel K; Böhmer R; Goberna R; Fussgänger R
    Digestion; 1972; 6(3):146-51. PubMed ID: 4199027
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on new sulfonylurea derivatives and their metabolites in isolated Langerhans's islets of the rat pancreas (author's transl].
    Krause U; Puchinger H; Wacker A
    Arzneimittelforschung; 1975 Aug; 25(8):1231-3. PubMed ID: 810148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
    Loubatiéres A; Mariani MM; Ribes G; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical and morphological events associated with the development of fetal rat pancreas "in vivo" and "in vitro": effect of glucagon and of other agents.
    Lambert AE; Orci L; Kanazawa Y; Jeanrenaud B; Renold AE
    Acta Isot (Padova); 1970; 10(3):191-204. PubMed ID: 4334397
    [No Abstract]   [Full Text] [Related]  

  • 8. [Secretion of insulin under the influence of sulfonylurea derivates (SH)].
    Rothenbuchner G; Raptis S; Pfeiffer EF
    Wien Z Inn Med; 1973; 54(2):69-77. PubMed ID: 4203274
    [No Abstract]   [Full Text] [Related]  

  • 9. Special pharmacology of the new sulfonylurea glimepiride.
    Geisen K
    Arzneimittelforschung; 1988 Aug; 38(8):1120-30. PubMed ID: 2904269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potentiating effect of the simultaneous administration of tolbutamide, glibenclamide, and gliclazide on the development of alloxan-induced diabetes in rats.
    Katsumata K; Katsumata Y
    Horm Metab Res; 1990 Jan; 22(1):51-2. PubMed ID: 2106472
    [No Abstract]   [Full Text] [Related]  

  • 11. Huang-Lian-Jie-Du-Tang supplemented with Schisandra chinensis Baill. and Polygonatum odoratum Druce improved glucose tolerance by potentiating insulinotropic actions in islets in 90% pancreatectomized diabetic rats.
    Park S; Hong SM; Ahn IS; Kim YJ; Lee JB
    Biosci Biotechnol Biochem; 2009 Nov; 73(11):2384-92. PubMed ID: 19897925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)].
    Haupt E; Beyer J; Schöffling K
    Dtsch Med Wochenschr; 1974 Mar; 99(9):385-8. PubMed ID: 4208186
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological study of a new hypoglycaemic sulphonamide: glisoxepid (RP 22410).
    Loubatières A; Mariani MM; Ribes G; Alric R; Agot H
    Diabetologia; 1972 Feb; 8(1):29-36. PubMed ID: 4554823
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of feeding and fasting on the insulin secretory response to glucose and sulfonylureas in intact rats and isolated perfused rat pancreas.
    Bosboom RS; Zweens J; Bouman PR
    Diabetologia; 1973 Aug; 9(4):243-50. PubMed ID: 4203349
    [No Abstract]   [Full Text] [Related]  

  • 15. Significance of acid amyloglucosidase in sulphonylurea-induced insulin release.
    Lundquist I
    Diabetologia; 1974 Dec; 10(6):717-24. PubMed ID: 4374400
    [No Abstract]   [Full Text] [Related]  

  • 16. Uptake of glibornuride by microdissected pancreatic islets.
    Täljedal IB
    Horm Res; 1974; 5(4):211-6. PubMed ID: 4210148
    [No Abstract]   [Full Text] [Related]  

  • 17. [Molecular mechanism of action of sulfonylureas].
    Ammon HP
    Dtsch Med Wochenschr; 1988 May; 113(21):864-70. PubMed ID: 3286184
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of glycemia level on insulin secretion caused by an hypoglycemic sulfamide (glisoxepide) in dogs].
    Loubatières AL; Ribes G; Loubatières-Mariani MM
    C R Seances Soc Biol Fil; 1972; 166(8):1047-50. PubMed ID: 4573746
    [No Abstract]   [Full Text] [Related]  

  • 19. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
    Beyer J; Cordes U; Sell G; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
    [No Abstract]   [Full Text] [Related]  

  • 20. [Functional status of beta-cells of the pancreas in long-term administration of hypoglycemic sulfanilamides in patients with glucose tolerance disorder].
    Zhurova MV; Sergeeva SL
    Probl Endokrinol (Mosk); 1987; 33(4):5-8. PubMed ID: 3116535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.